Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Sun Pharma Advanced Research Co. Ltd. ( (IN:SPARC) ) is now available.
Sun Pharma Advanced Research Company Ltd. informed exchanges about the conduct of its Extraordinary General Meeting on 9 February 2026, held via video conferencing with full board attendance and requisite quorum. Shareholders were provided remote and electronic voting facilities, relevant documentation for inspection, and an opportunity to question management on the meeting’s agenda.
The key business item placed before shareholders was a special resolution to approve the issue of convertible warrants on a preferential basis to a member of the company’s promoter group. This proposed capital raise, backed by valuation and compliance certifications and in-principle approval applications to NSE and BSE, signals a move to strengthen the company’s funding and promoter support, with implications for ownership structure and future growth plans.
More about Sun Pharma Advanced Research Co. Ltd.
Sun Pharma Advanced Research Company Ltd. operates in the pharmaceutical research and development sector, focusing on innovative therapies and drug delivery technologies. The company primarily serves global and domestic markets through advanced research pipelines that support its parent group’s broader healthcare and specialty pharma portfolio.
Average Trading Volume: 557,952
Technical Sentiment Signal: Sell
Current Market Cap: 45.12B INR
Find detailed analytics on SPARC stock on TipRanks’ Stock Analysis page.